Zhejiang Starry Pharmaceutical

Zhejiang Starry Pharmaceutical is a leading Chinese pharmaceutical company specializing in the research, development, and large-scale manufacturing of X-ray contrast agents and Magnetic Resonance Imaging (MRI) contrast agents. The company is one of the world's largest suppliers of iodine-based contrast media APIs, including iohexol, iopamidol, and iodixanol. In addition to its core imaging business, Starry Pharmaceutical produces various active pharmaceutical ingredients (APIs) and finished dosage forms across therapeutic areas such as cardiovascular and anti-infectives. It operates as a significant CDMO partner for global pharmaceutical firms, leveraging its high-capacity GMP manufacturing facilities. Headquartered in Zhejiang, China, the company is publicly traded on the Shanghai Stock Exchange and maintains a strong presence in international markets including Europe and North America.